Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.

Gupta, Sarthak; Nakabo, Shuichiro; Chu, Jun; Hasni, Sarfaraz; Kaplan, Mariana J

Gupta, Sarthak; Nakabo, Shuichiro; Chu, Jun; Hasni, Sarfaraz; Kaplan, Mariana J.

Gupta S; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA sarthak.gupta@nih.gov.
Nakabo S; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Chu J; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Hasni S; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kaplan MJ; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Ann Rheum Dis ; 2021 Jan 15.

Article in English | MEDLINE | ID: covidwho-1031909

Keywords

Covid-19; autoantibodies; cytokines; systemic lupus erythematosus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Long Covid Language: English Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-219648

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google